What are Cytokine immunotherapy drugs?

Cytokine immunotherapy drugs are pharmacologic agents that share a common mechanism (typically targeting IL-2 receptor (CD25)). 1 are currently marketed, with 2 more in clinical development.

What are the marketed Cytokine immunotherapy drugs?

Marketed Cytokine immunotherapy drugs include Interleukin 2.

Cytokine immunotherapy

1 marketed 1 in Phase 3 1 in Phase 2

This page covers all Cytokine immunotherapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting IL-2 receptor (CD25), IL-2 receptor, IL-2 receptor (CD25, CD122, CD132).

Targets

IL-2 receptor (CD25) · IL-2 receptor · IL-2 receptor (CD25, CD122, CD132)

Marketed (1)

Interleukin 2 · Assistance Publique - Hôpitaux de Paris · Oncology
Interleukin-2 (IL-2) is a cytokine that activates and proliferates T cells and natural killer cells to enhance immune response against cancer and infections.

Phase 3 pipeline (1)

IL2 · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · Oncology
IL-2 (interleukin-2) is a cytokine that activates and expands T cells and natural killer cells to enhance anti-tumor immune responses.

Phase 2 pipeline (1)

Dose D2 of Interleukin-2 · Assistance Publique - Hôpitaux de Paris · Oncology
Interleukin-2 activates and expands T cells and natural killer cells to enhance anti-tumor immune responses.